Spartalizumab Antibody
Spartalizumab (PDR001) is a humanized anti-PD-1 monoclonal antibody that potently inhibits PD-1/PD-L1/PD-L2 interactions. It is utilized in research, including in vitro and in vivo studies, for investigating immunotherapies against cancers such as anaplastic thyroid carcinoma (ATC) .
Product Specifications
Product Name Alternative
PD-L1, PDL1, PDR 001, PDR001, PDR-001, Spartalizumab, Spartalizumab (anti-PD-1), PD1/PDL1, PD1, PD-1, anti-PD-1
Target
PD-1/PD-L1
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation
Concentration
2.56 mg/mL
Purity
95.10% (May vary between batches)
Molecular Weight
145.74 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
